You are cordially invited to join Dr. Paul Haluska in a teleconference for an update on and to discuss your questions/comments about the North Central Cancer Treatment Group Trial N0733 for HER2 positive breast cancer patients who have had their cancer back or grow through first line treatment with Herceptin.  In this trial, we […]

Tags: Events, Research Results by erailey
No Comments »

The Alamo Breast Cancer Foundation recently published the Hot Topics webcast from the 2008 San Antonio Breast Cancer Symposium. Click here to view the online webcast.
Alamo Breast Cancer Foundation distributes scholarships to patient advocates nationwide […]

Tags: Conference reports by erailey
No Comments »

News from the ASCO GU Symposium, February 24, 2009
* The development of a personalized risk assessment tool that combines prostate-specific antigen (PSA) test results with additional prostate cancer risk factors to more accurately predict a man’s future risk of developing prostate cancer, compared with PSA test results alone
* A study finding that a novel molecular […]

Tags: Conference reports, Research Results by erailey
No Comments »

Studies highlighted in ASCO press release from the GI Symposium in January
* An economic analysis showing that routine testing for KRAS gene mutations in patients with metastatic colorectal cancer could save the U.S. health system up to $604 million per year in the cost of the drug cetuximab (Erbitux). Recent studies have shown that cetuximab […]

Tags: Conference reports, Research Results by erailey
No Comments »

Green tea products have become regarded as a valuable health supplement, as studies have shown evidence of its benefit against a variety of diseases, including cancer. However, a new study suggests that some components of green tea may counteract the anticancer effects of one cancer therapy, bortezomib (Velcade®), and may be contraindicated for patients taking […]

Tags: Research Results by erailey
No Comments »